Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Apollomics A | APLM | Nov 15, 2024 | 0.10 | -8.32 |
AppFolio A | APPF | Nov 15, 2024 | 230.02 | -1.43 |
Appian A | APPN | Nov 15, 2024 | 36.43 | -3.11 |
Apple | AAPL | Nov 15, 2024 | 225.00 | -1.41 |
Apple Hospitality REIT | APLE | Nov 15, 2024 | 15.50 | -0.58 |
Applied Digital | APLD | Nov 15, 2024 | 7.23 | +5.39 |
Applied DNA Sciences | APDN | Nov 15, 2024 | 0.16 | -6.79 |
Applied Industrial Technologies | AIT | Nov 15, 2024 | 266.73 | -1.55 |
Applied Materials | AMAT | Nov 15, 2024 | 168.88 | -9.20 |
Applied Optoelectronics | AAOI | Nov 15, 2024 | 26.80 | -4.80 |
Applied Therapeutics | APLT | Nov 15, 2024 | 8.69 | -3.55 |
Applovin A | APP | Nov 15, 2024 | 291.09 | +2.32 |
AppTech Payments | APCX | Nov 15, 2024 | 0.47 | -2.69 |
Aprea Therapeutics | APRE | Nov 15, 2024 | 3.25 | -2.99 |
AptarGroup | ATR | Nov 15, 2024 | 166.49 | -4.37 |
Aptevo Therapeutics | APVO | Nov 15, 2024 | 0.21 | -12.45 |
Aptiv | APTV | Nov 15, 2024 | 52.93 | -2.04 |
Aptorum Group A | APM | Nov 15, 2024 | 0.68 | -38.00 |
Aptose Biosciences | APTO | Nov 15, 2024 | 0.36 | -5.28 |
APx Acquisition I A | APXI | Nov 15, 2024 | 11.87 | +0.17 |
APx Acquisition I Unit | APXIU | Nov 15, 2024 | 11.55 | 0.00 |
Apyx Medical | APYX | Nov 15, 2024 | 1.26 | -2.33 |
Aqua Metals | AQMS | Nov 15, 2024 | 1.67 | -12.57 |
AquaBounty Technologies | AQB | Nov 15, 2024 | 1.00 | -2.07 |
Aquaron Acquisition | AQU | Nov 15, 2024 | 11.00 | 0.00 |
Aquaron Acquisition Units | AQUNU | Nov 15, 2024 | 11.15 | 0.00 |
Aquestive Therapeutics | AQST | Nov 15, 2024 | 4.44 | -2.84 |
Aramark | ARMK | Nov 15, 2024 | 37.36 | -3.41 |
ARB IOT Group | ARBB | Nov 15, 2024 | 0.48 | -14.59 |
Arbe Robotics | ARBE | Nov 15, 2024 | 1.61 | -2.42 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.